Literature DB >> 19750427

Acute liver failure in a metropolitan area in Germany: a retrospective study (2002 - 2008).

A Canbay1, C Jochum, L P Bechmann, S Festag, R K Gieseler, Z Yüksel, P Lütkes, F H Saner, A Paul, G Gerken.   

Abstract

OBJECTIVES: To determine current etiologies of acute liver failure (ALF) and clinical and laboratory parameters associated with the outcome upon ALF, so as to identify the frequency of present causes of ALF in Germany as well as potential new prognostic parameters. PATIENTS: 134 adult patients (63 % females / 37 % males) aged 41 +/- 16 years (median: 38 years) with established ALF criteria. DESIGN AND
SETTING: A retrospective study (1 / 2002 - 4 / 2008) on ALF patients from the Ruhr Area, the largest urban region located in northwestern Germany. Clinical and laboratory data were collected for a period of four weeks after study admission.
RESULTS: Etiologies of ALF were identified as drug toxicity (39.6 % of the cases); combined viral hepatitides (23.1 %); or miscellaneous (16.4 %). In 20.9 % of the cases, the etiology remained indeterminate. Overall patient survival at four weeks was 81.3 %. While 89 patients (66.4 %) recovered under best supportive therapy, 26 patients (19.4 %) had to undergo liver transplantation. Increased body mass indices were significantly (p < 0.003) associated with a poor outcome. Intriguingly, high levels of cholestatic enzymes significantly (p < 0.01) correlated with a positive outcome.
CONCLUSIONS: In providing first data on current ALF etiologies Germany, this study reveals that drug toxicity - in particular due to acetaminophen - has replaced viral hepatitis as the most single frequent cause of ALF in a densely populated urban area; this correlates with similar findings in the USA, the UK and Scandinavia. Lower body mass indices and elevated cholestatic enzyme levels had statistically significant prognostic power. (c)Georg Thieme Verlag KG Stuttgart - New York.

Entities:  

Mesh:

Year:  2009        PMID: 19750427     DOI: 10.1055/s-0028-1109058

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  20 in total

1.  [Role of vitamin K antagonists from a hepatologist's point of view].

Authors:  G Kneiseler; A Canbay; G Gerken
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

Review 2.  Acute liver failure: a life-threatening disease.

Authors:  Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

3.  A new treatment strategy for acute liver failure.

Authors:  Kazuhiro Kotoh; Masaki Kato; Motoyuki Kohjima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Hepatol       Date:  2010-11-27

Review 4.  [Acute liver failure. How much diagnostic work-up and therapy does my patient need?].

Authors:  J Hadem; A S Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

5.  Sodium 4-phenylbutyric acid prevents murine acetaminophen hepatotoxicity by minimizing endoplasmic reticulum stress.

Authors:  Hiromi Kusama; Kazuyoshi Kon; Kenichi Ikejima; Kumiko Arai; Tomonori Aoyama; Akira Uchiyama; Shunhei Yamashina; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2016-09-06       Impact factor: 7.527

6.  Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.

Authors:  Marwan Ghabril; Jiezhun Gu; Lindsay Yoder; Laura Corbito; Amit Ringel; Christian D Beyer; Raj Vuppalanchi; Huiman Barnhart; Paul H Hayashi; Naga Chalasani
Journal:  Gastroenterology       Date:  2019-07-11       Impact factor: 22.682

7.  [Paracetamol for perioperative analgesia. Old substance - new insights].

Authors:  P K Zahn; R Sabatowski; S A Schug; U M Stamer; E M Pogatzki-Zahn
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

Review 8.  Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis.

Authors:  Andreas Pascher; Maxim Nebrig; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2013-03-08       Impact factor: 5.594

Review 9.  Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Pharm Res       Date:  2013-03-06       Impact factor: 4.200

10.  Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications.

Authors:  Mitchell R McGill; Margitta Lebofsky; Hye-Ryun K Norris; Matthew H Slawson; Mary Lynn Bajt; Yuchao Xie; C David Williams; Diana G Wilkins; Douglas E Rollins; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.